SCREENING VON KONJUGIERTEN ANTIKÖRPERN

European patent · EP2872894 · In force

Register entry

Publication number
EP2872894
Application number
EP13737208
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 10, 2013
Published
May 20, 2015
Granted
Apr 17, 2019
Protection ends at the latest
Jul 9, 2033
Next annual fee due
Jul 31, 2027
IPC classes
G01N 33/543 (2006.01)
G01N 33/68 (2006.01)
C07K 16/00 (2006.01)
Priority
US 201261671128 P 13.07.2012
PCT application
PCT/EP2013/064605 10.07.2013
PCT publication
WO2014/009426 16.01.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Dec 10, 2024

    Next annual fee due on

    Next annual fee due on
    31.07.2024 → 31.07.2025

    Published in Swissreg on 10.12.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 8, 2022

    Change

    Published in Swissreg on 08.08.2022

  6. Apr 17, 2019

    Granted

    Published in Swissreg on 17.04.2019

Parties

Holder

Innate Pharma

117 Avenue de Luminy, 13009 Marseille, FR

Paul Scherrer Institut

5232 Villigen PSI

Inventor

SCHIBLI, Roger

CH-5400 Baden

BREGEON, Delphine

F-13007 Marseille, FR

ROMAGNE, François

F-13009 Marseille, FR

DENNLER, Patrick

CH-5430 Wettingen

FISCHER, Eliane

CH-8193 Eglisau

BELMANT, Christian

F-83140 Six-Fours-lès-Plages, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.